These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

580 related articles for article (PubMed ID: 28760771)

  • 21. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
    Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
    Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activity of Group 2 Innate Lymphoid Cells is Associated with Chronic Inflammation and Dysregulated Metabolic Homoeostasis in Type 2 Diabetic Nephropathy.
    Lu P; Ji X; Wan J; Xu H
    Scand J Immunol; 2018 Feb; 87(2):99-107. PubMed ID: 29194733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Do resident renal mast cells play a role in the pathogenesis of diabetic nephropathy?
    Balakumar P; Reddy J; Singh M
    Mol Cell Biochem; 2009 Oct; 330(1-2):187-92. PubMed ID: 19415459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophages and diabetic nephropathy.
    Tesch GH
    Semin Nephrol; 2010 May; 30(3):290-301. PubMed ID: 20620673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular and humoral immune responses in the early stages of diabetic nephropathy in NOD mice.
    Xiao X; Ma B; Dong B; Zhao P; Tai N; Chen L; Wong FS; Wen L
    J Autoimmun; 2009 Mar; 32(2):85-93. PubMed ID: 19200691
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tubular overexpression of Gremlin in transgenic mice aggravates renal damage in diabetic nephropathy.
    Marchant V; Droguett A; Valderrama G; Burgos ME; Carpio D; Kerr B; Ruiz-Ortega M; Egido J; Mezzano S
    Am J Physiol Renal Physiol; 2015 Sep; 309(6):F559-68. PubMed ID: 26155842
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Oxidative Stress and Inflammatory Factors in Diabetic Kidney Disease.
    Aghadavod E; Khodadadi S; Baradaran A; Nasri P; Bahmani M; Rafieian-Kopaei M
    Iran J Kidney Dis; 2016 Nov; 10(6):337-343. PubMed ID: 27903991
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum Inflammatory and Immune Mediators Are Elevated in Early Stage Diabetic Nephropathy.
    Perlman AS; Chevalier JM; Wilkinson P; Liu H; Parker T; Levine DM; Sloan BJ; Gong A; Sherman R; Farrell FX
    Ann Clin Lab Sci; 2015; 45(3):256-63. PubMed ID: 26116588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Postischemic inflammatory syndrome: a critical mechanism of progression in diabetic nephropathy.
    Kelly KJ; Burford JL; Dominguez JH
    Am J Physiol Renal Physiol; 2009 Oct; 297(4):F923-31. PubMed ID: 19656916
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Roles of pattern recognition receptors in diabetic nephropathy.
    Zhou ZF; Jiang L; Zhao Q; Wang Y; Zhou J; Chen QK; Lv JL
    J Zhejiang Univ Sci B; 2020 Mar.; 21(3):192-203. PubMed ID: 32133797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of Toll-like receptors in diabetic nephropathy.
    Mudaliar H; Pollock C; Panchapakesan U
    Clin Sci (Lond); 2014 May; 126(10):685-94. PubMed ID: 24490813
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The NLRP3 inflammasome in kidney disease and autoimmunity.
    Hutton HL; Ooi JD; Holdsworth SR; Kitching AR
    Nephrology (Carlton); 2016 Sep; 21(9):736-44. PubMed ID: 27011059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Interplay of Renin-Angiotensin System and Toll-Like Receptor 4 in the Inflammation of Diabetic Nephropathy.
    Feng Q; Liu D; Lu Y; Liu Z
    J Immunol Res; 2020; 2020():6193407. PubMed ID: 32411800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Macrophage-derived tumor necrosis factor-α mediates diabetic renal injury.
    Awad AS; You H; Gao T; Cooper TK; Nedospasov SA; Vacher J; Wilkinson PF; Farrell FX; Brian Reeves W
    Kidney Int; 2015 Oct; 88(4):722-33. PubMed ID: 26061548
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of complement components by cells of the immune system.
    Lubbers R; van Essen MF; van Kooten C; Trouw LA
    Clin Exp Immunol; 2017 May; 188(2):183-194. PubMed ID: 28249350
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The immunobiology of the receptor of advanced glycation end-products: trends and challenges.
    González I; Romero J; Rodríguez BL; Pérez-Castro R; Rojas A
    Immunobiology; 2013 May; 218(5):790-7. PubMed ID: 23182709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.